Evaluating healthcare policies and possible funding pathways for CAR-T therapies in KSA
Client Situation
Our client is a leading provider of targeted therapies for treatment of rare diseases. They wanted to understand the evolving healthcare policies, potential access and funding opportunities in the private and public sector for DLBCL CAR-T therapies in KSA.
Project Scope
To understand the healthcare policies and potential access, reimbursement, funding opportunities for DLBCL CAR-T therapies in KSA
Conducted extensive primary research to get detailed insights on:
○Pricing and reimbursement process for high cost therapies in public and private sector
○National and hospital level and alternative funding pathways feasible for DLBCL CAR-T therapies
○Changes in healthcare policies in future impacting public funding for CAR-T in future
Results
Enabled our client to understand local funding and access pathways for high cost therapies
Recommended approaches from payer viewpoint to secure funding for high cost therapies in both the private and public sectors